Skip to main content
Clinical Trials/ACTRN12605000745640
ACTRN12605000745640Not yet recruitingPhase 4

Does metoclopramide improve quality of endoscopy in acute upper gastrointestinal bleeding?.

Pharmacy department , Southerm Health.0 sites70 target enrollmentStarted: November 16, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to ot stated (—)
Sex
All

Inclusion Criteria

  • Upper GI bleeding defined as either fresh and bright red or coffee ground haematemesis, Admission within 12 hours of initial clinical signs of bleeding and Written informed consent from patient.

Exclusion Criteria

  • Previous allergy to metoclopramide, use of Nasogastric tube or gastric lavage, Prior gastrectomy, Pregnancy or lactation, Unable to give informed consent for any reason, Parkinsons disease and other contraindication to use of metoclopramide, Severe renal impairment and Advanced liver disease .

Investigators

Sponsor
Pharmacy department , Southerm Health.

Similar Trials

Does metoclopramide improve quality of... | Clinical Trial